123 related articles for article (PubMed ID: 1342967)
1. Expression of stromelysin 3 in the stromal elements of human basal cell carcinoma.
Wagner SN; Ruhri C; Kunth K; Holecek BU; Goos M; Höfler H; Atkinson MJ
Diagn Mol Pathol; 1992 Sep; 1(3):200-5. PubMed ID: 1342967
[TBL] [Abstract][Full Text] [Related]
2. Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers.
Kerkelä E; Ala-aho R; Lohi J; Grénman R; M-Kähäri V; Saarialho-Kere U
Br J Cancer; 2001 Mar; 84(5):659-69. PubMed ID: 11237387
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of stromelysin-3 in basal cell carcinomas.
Majmudar G; Nelson BR; Jensen TC; Voorhees JJ; Johnson TM
Mol Carcinog; 1994 Jan; 9(1):17-23. PubMed ID: 8297480
[TBL] [Abstract][Full Text] [Related]
4. Expression of stromelysin-3 in medullary carcinoma of the breast.
Holm R; Flørenes VA; Erikstein B; Nesland JM
Anticancer Res; 1997; 17(5B):3725-7. PubMed ID: 9427769
[TBL] [Abstract][Full Text] [Related]
5. Expression of stromelysin 3 in basal cell carcinomas.
Cribier B; Noacco G; Peltre B; Grosshans E
Eur J Dermatol; 2001; 11(6):530-3. PubMed ID: 11701402
[TBL] [Abstract][Full Text] [Related]
6. Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas.
Muller D; Wolf C; Abecassis J; Millon R; Engelmann A; Bronner G; Rouyer N; Rio MC; Eber M; Methlin G
Cancer Res; 1993 Jan; 53(1):165-9. PubMed ID: 7677979
[TBL] [Abstract][Full Text] [Related]
7. Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas.
Bolon I; Devouassoux M; Robert C; Moro D; Brambilla C; Brambilla E
Am J Pathol; 1997 May; 150(5):1619-29. PubMed ID: 9137088
[TBL] [Abstract][Full Text] [Related]
8. Matrix-degrading metalloproteinases in tumor progression.
Matrisian LM; Wright J; Newell K; Witty JP
Princess Takamatsu Symp; 1994; 24():152-61. PubMed ID: 8983072
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinases during murine chorioallantoic placenta maturation.
Teesalu T; Masson R; Basset P; Blasi F; Talarico D
Dev Dyn; 1999 Mar; 214(3):248-58. PubMed ID: 10090151
[TBL] [Abstract][Full Text] [Related]
10. Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization.
Pyke C; Ralfkiaer E; Huhtala P; Hurskainen T; Danø K; Tryggvason K
Cancer Res; 1992 Mar; 52(5):1336-41. PubMed ID: 1310643
[TBL] [Abstract][Full Text] [Related]
11. Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions.
Bolon I; Brambilla E; Vandenbunder B; Robert C; Lantuejoul S; Brambilla C
Lab Invest; 1996 Jul; 75(1):1-13. PubMed ID: 8683934
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis.
Tsukifuji R; Tagawa K; Hatamochi A; Shinkai H
Br J Cancer; 1999 Jun; 80(7):1087-91. PubMed ID: 10362121
[TBL] [Abstract][Full Text] [Related]
13. Detection of mRNAs encoding collagenase I and stromelysin 2 in carcinomas of the head and neck by in situ hybridization.
Polette M; Clavel C; Muller D; Abecassis J; Binninger I; Birembaut P
Invasion Metastasis; 1991; 11(2):76-83. PubMed ID: 1655673
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma.
Imanishi Y; Fujii M; Tokumaru Y; Tomita T; Kanke M; Kanzaki J; Kameyama K; Otani Y; Sato H
Hum Pathol; 2000 Aug; 31(8):895-904. PubMed ID: 10987249
[TBL] [Abstract][Full Text] [Related]
15. Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma.
Bramhall SR; Neoptolemos JP; Stamp GW; Lemoine NR
J Pathol; 1997 Jul; 182(3):347-55. PubMed ID: 9349239
[TBL] [Abstract][Full Text] [Related]
16. Gene expression of matrix metalloproteinase-1 (interstitial collagenase) and matrix metalloproteinase-3 (stromelysin-1) in basal cell carcinoma by in situ hybridization using chondroitin ABC lyase.
Tsukifuji R; Sakai Y; Hatamochi A; Shinkai H
Histochem J; 1997 May; 29(5):401-7. PubMed ID: 9184854
[TBL] [Abstract][Full Text] [Related]
17. Stromelysin-3 mRNA associated with myofibroblasts is overexpressed in aggressive basal cell carcinoma and in dermatofibroma but not in dermatofibrosarcoma.
Undén AB; Sandstedt B; Bruce K; Hedblad M; Stahle-Bäckdahl M
J Invest Dermatol; 1996 Aug; 107(2):147-53. PubMed ID: 8757754
[TBL] [Abstract][Full Text] [Related]
18. Stromelysin-3 gene expression in human cancer: an overview.
Rouyer N; Wolf C; Chenard MP; Rio MC; Chambon P; Bellocq JP; Basset P
Invasion Metastasis; 1994-1995; 14(1-6):269-75. PubMed ID: 7657519
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
O'Grady A; Dunne C; O'Kelly P; Murphy GM; Leader M; Kay E
Histopathology; 2007 Dec; 51(6):793-804. PubMed ID: 18042068
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of immunohistochemical markers with invasiveness and histologic differentiation in squamous cell carcinoma and basal cell carcinoma of the skin.
Son KD; Kim TJ; Lee YS; Park GS; Han KT; Lim JS; Kang CS
J Surg Oncol; 2008 Jun; 97(7):615-20. PubMed ID: 18404670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
